CYN 101Alternative Names: CYN-101
Latest Information Update: 11 Jul 2016
At a glance
- Originator Cynvec
- Class Cancer vaccines; Oncolytic viruses
- Mechanism of Action Apoptosis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Ovarian cancer
Most Recent Events
- 11 Jul 2016 Preclinical development is ongoing in USA
- 02 Jun 2009 Preclinical trials in Ovarian cancer in USA (Parenteral)